Form 6-K Itau Unibanco Holding For: Sep 30
Tweet
Share
E-mail
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of
September 2016
Commission File Number: 001-15276
Itaú Unibanco Holding S.A.
(Exact name of registrant as specified in its charter)
Itaú Unibanco Holding S.A.
(Translation of Registrant’s Name into English)
Praça Alfredo Egydio de Souza Aranha, 100-Torre Conceicao - CEP
04344-902 São Paulo, SP, Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F: x Form 40-F: ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes: ¨ No: x
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes: ¨ No: x
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes: ¨ No: x
If
“Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-___________________.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Itaú Unibanco Holding S.A. | ||||
| (Registrant) | ||||
| Date: September 30, 2016 | By: | /s/ Marcelo Kopel | ||
| Name: | Marcelo Kopel | |||
| Title: | Investor Relations Officer | |||
| By: | /s/ Eduardo Mazzilli de Vassimon | |||
| Name: | Eduardo Mazzilli de Vassimon | |||
| Title: | Chief Financial Officer | |||
EXHIBIT INDEX
| 99.1 | ANNOUNCEMENT TO THE MARKET |
Exhibit 99.1
Itaú Unibanco Holding S.A.
| CNPJ 60.872.504/0001-23 | A Publicly Listed Company | NIRE 35300010230 |
ANNOUNCEMENT TO THE MARKET
ITAÚ UNIBANCO HOLDING S.A. (“Company”) announces to its stockholders and the market in general that, on this date, an agreement for the share purchase agreement (“Agreement”) was entered into with Banco BMG S.A. (“BMG”) by means of which Itaú Unibanco S.A. (“Itaú Unibanco”), acting by itself or through its affiliates, undertakes to purchase the totality of the equity interest held by BMG in Banco Itaú BMG Consignado S.A. (“Itaú BMG Consignado”), corresponding to 40% of its total share capital, and becoming the holder of 100% of Itaú BMG Consignado’s total share capital upon the consummation of the acquisition.
Itaú Unibanco shall pay approximately R$ 1.28 billion to BMG, adjusted by the CDI variation since December 31, 2015 until the effective date of the transfer of shares, after certain conditions set forth in the Agreement are met, including the obtainment of the applicable regulatory authorizations.
Itaú Unibanco and BMG will maintain an association by means of the execution of a new commercial agreement for the distribution of payroll loans of Itaú BMG Consignado and its affiliates, on an exclusive basis, through certain distribution channels linked to BMG and its affiliates.
The Company will maintain the leadership among private banks in this segment considering, in addition to its other payroll loan operations, the Itaú BMG Consignado portfolio, which on August 31, 2016 corresponded to approximately R$ 29.0 billion. This transaction will not produce material results for Itaú Unibanco in 2016.
The Company emphasizes, through this transaction, its strategy to operate with assets of lower risk and attractive profitability, and its commitment with the quality of services provided to its clients and the creation of long-term value to its stockholders.
São Paulo, September 29, 2016
MARCELO KOPEL
Investor Relations Officer
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ITAÚ UNIBANCO - Interactive Meeting 1Q24
- Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Rese
- LSI Industries Reports Fiscal 2024 Third Quarter Results and Declares Quarterly Cash Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
